1. Academic Validation
  2. Synthesis of tetrahydronaphthalene lignan esters by intramolecular cyclization of ethyl p-azidophenyl-2-phenylalkanoates and evaluation of the growth inhibition of human tumor cell lines

Synthesis of tetrahydronaphthalene lignan esters by intramolecular cyclization of ethyl p-azidophenyl-2-phenylalkanoates and evaluation of the growth inhibition of human tumor cell lines

  • J Med Chem. 2011 May 12;54(9):3175-87. doi: 10.1021/jm101182s.
Orlando Pinto 1 João Sardinha Pedro D Vaz Fátima Piedade Maria J Calhorda Rudolph Abramovitch Nair Nazareth Madalena Pinto Maria S J Nascimento Amélia P Rauter
Affiliations

Affiliation

  • 1 Universidade de Lisboa, Faculdade de Ciências, Centro de Química e Bioquímica/Departamento de Química e Bioquímica (CQB/DQB), Ed. C8, Piso 5, 1749-016 Lisboa, Portugal.
Abstract

Intramolecular cyclization via nitrenium ion of 2-phenylpentanoic/2-phenylbutanoic acid esters with a terminal p-azidophenyl group gives direct access to tetrahydronaphthalene lignan esters. The p-azidophenyl-substituted butanoate led to an ethyl spirodienone carboxylate, while its homologue pentanoate gave ethyl 4-(4-aminophenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxylate in good yield. In contrast, the m-azidophenyl-substituted esters suffered aromatic nucleophilic addition of trifluoromethanesulfonate. X-ray crystallography established unequivocally the end products structure, and density functional theory studies were performed to rationalize the cyclization outcome. Reaction intermediates and end products were evaluated for their capacity to inhibit in vitro growth of the cell lines MCF-7 (breast Cancer), NCI-H460 (lung Cancer), SF-268 (CNS Cancer), and UACC-62 (melanoma). Growth inhibition of breast, lung, and CNS Cancer cell lines was observed with the spirodienone carboxylate, the m-nitrophenylalkyl iodides, and p-phenyl-substituted elongated ethyl esters, namely, the p-nitrophenylpentanoate and p-aminophenylbutanoate, with the latter being also effective on the melanoma cell line.

Figures